What is the best treatment strategy for obstructive sleep apnoea-related hypertension?

Hypertens Res. 2018 Dec;41(12):1070-1072. doi: 10.1038/s41440-018-0114-5. Epub 2018 Oct 15.

Bruno Revol^{1

2

3}, Ingrid Jullian-Desayes^{4

5}, Sébastien Bailly^{1

2}, Lucas Regnaut^{1

2}, Renaud Tamisier^{1

2}, Jean-Louis Pepin^{6

7}, Marie Joyeux-Faure^{1

2}

¹ HP2 Laboratory, INSERM U1042 Unit, Grenoble Alpes University, Grenoble, France.
² Thorax and Vessels Division, Grenoble Alpes University Hospital, EFCR, Grenoble, France.
³ Pharmacovigilance Department, Grenoble Alpes University Hospital, Grenoble, France.
⁴ HP2 Laboratory, INSERM U1042 Unit, Grenoble Alpes University, Grenoble, France. Ijulliandesayes@chu-grenoble.fr.
⁵ Thorax and Vessels Division, Grenoble Alpes University Hospital, EFCR, Grenoble, France. Ijulliandesayes@chu-grenoble.fr.
⁶ HP2 Laboratory, INSERM U1042 Unit, Grenoble Alpes University, Grenoble, France. JPepin@chu-grenoble.fr.
⁷ Thorax and Vessels Division, Grenoble Alpes University Hospital, EFCR, Grenoble, France. JPepin@chu-grenoble.fr.

No abstract available

Publication types